Form 4 for TDOC Teladoc Health, Inc.
Accepted 2023-05-05 00:00:00 ET · period of report 2023-05-03 · accession 0001415889-23-007439 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-05 | 2023-05-04 | TDOC | Jensen Claus Torp | Chief INNOVATION Off | S - Sale+OE | $25.64 | -1,699 | 13.5K | -11% | -$43.6K |
| D | 2023-05-05 | 2023-05-03 | TDOC | Jensen Claus Torp | Chief INNOVATION Off | M - OptEx | — | +5,616 | 15.2K | +58% | — |
| D | 2023-05-05 | 2023-05-03 | TDOC | Jensen Claus Torp | Chief INNOVATION Off | M - OptEx | $0.00 | -5,616 | 5,617 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-04 | S | D | 1,699 | $25.64 | 13,540 | D | — | — | (F2) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. |
| 2 | Common | Common Stock | 2023-05-03 | M | A | 5,616 | — | 15,239 | D | — | — | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 3 | Derivative | Restricted Stock Units | 2023-05-03 | M | D | 5,616 | $0.00 | 5,617 | D | — · — to — | 5,616 Common Stock | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F3) On May 3, 2021, the reporting person was granted 16,849 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. |